Aurobindo Pharma announced that its wholly owned subsidiary, Aurobindo Pharma USA, Inc., has received approval from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC. The...
Pharmaceutical
Sun Pharma to acquire 100% stake in Innovcare Lifesciences for Rs 271 crore
Sun Pharmaceutical Industries said that it has entered into an agreement to acquire 100% of the outstanding shares of Innovcare Lifesciences for a total consideration of Rs 271.2 crore. Innovcare Lifesciences is engaged...
AbbVie sharpens immunology focus with $10.9 billion Apogee deal
AbbVie said on Monday it would buy Apogee Therapeutics for $10.9 billion, the company’s largest buyout in more than five years, as it seeks to bolster its treatment pipeline for inflammatory diseases like atopic...
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transaction
Sun Pharmaceutical Industries Ltd will acquire Mumbai-based Innovcare Lifesciences Private Ltd for about $28.7 million (around Rs 271.2 crore) in an all-cash deal, as India’s largest drugmaker looks to strengthen...
Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett Company
Aurobindo Pharma’s US subsidiary received U.S. Federal Trade Commission (FTC) approval to proceed with the acquisition of Lannett Company LLC in a deal valued at $250 million, the company announced on Monday. The...
AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports
AbbVie is nearing a deal to acquire inflammatory disease drug developer Apogee Therapeutics for about $10.9 billion in cash, the Financial Times reported on Friday, citing people familiar with the matter. The deal...
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon
Indian generic drug giant Aurobindo Pharma announced on Friday that it is on the verge of pulling off a major expansion in the United States after clearing a critical regulatory hurdle. The Hyderabad-based...
Zydus Lifesciences completes acquisition of Assertio
Zydus Lifesciences Ltd on Tuesday said it has completed the USD 166.4 million acquisition of US-based pharma company Assertio Holdings Inc. The company has successfully completed the cash tender offer, through wholly...
$10. 6 billion deal: GSK to buy US cancer specialist Nuvalent
British pharmaceutical group GSK announced Tuesday a $10.6-billion deal for Nuvalent, a Boston-based specialist in cancer treatments, furthering its push into both oncology and the United States. The deal includes...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. The companies were locked in...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. Here are some details: The companies...
Shilpa Biocare to acquire 30.4% stake in Barcelona-based Gate2Brain
Shilpa Medicare announced that its wholly owned subsidiary, Shilpa Biocare intends to make a strategic equity partnership of 30.4% in Gate2Brain. The investment of Euro 7 million includes cash infusion of Euro 0.5...
